Тонизирующие (энергетические) напитки: основные компоненты, эффективность и безопасность


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

Представлены современные данные об уровне потребления энергетических напитков, фармакокинетике и фармакодинамике основных компонентов напитков - кофеина и таурина, а также результаты исследования по безопасности входящих в состав энергетических напитков биологически активных компонентов.

Полный текст

Доступ закрыт

Об авторах

Р. Ханферьян

Федеральный исследовательский центр питания, биотехнологии и безопасности пищи

Email: khanferyan@ion.ru
доктор медицинских наук, профессор

Список литературы

  1. Scientific Opinion on the safety of caffeineEFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) // EFSA J. - 2015; 13 (5): 4102
  2. Dorfman L., Jarvik M. Comparative stimulant and diuretic actions of caffeine and theobromine in man // Clin. Pharmacol. Ther. - 1970; 11 (6): 869-72.
  3. Boothby W., Rowntree L. Drugs and basal metabolism // J. Pharmacol. Exp. Ther. - 1924; 22: 99-108.
  4. Haldi J., Bachmann G., Ensor C. et al. The effects of various amounts of caffeine on the gaseous exchange and the respiratory quotient in man // J. Nutr. -1941; 21: 307.
  5. Miller D., Stock M., Stuart J. The effects of caffeine and carnitine on the oxygen consumption of fed and fasted subjects // Proc. Nutr. Soc. - 1974; 33: 28A.
  6. Acheson K., Zahorska-Markiewicz B. Pittet Ph. et al. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals // Am. J. Clin. Nutr. - 1980; 33 (5): 989-97.
  7. Nathanson J. Caffeine and related methylxanthines: possible naturally occurring pesticides // Science. - 1984; 226 (4671): 184-7.
  8. Mathavan S., Premalatha Y., Christopher M. Effects of caffeine and theophylline on the fecundity of four lepidopteran species // Exp Biol. - 1985; 44 (2): 133-8.
  9. Hollingsworth R., Armstrong J., Campbell E. Caffeine as a repellent for slugs and snails // Nature. - 2002; 417: 915-6.
  10. Barone J., Roberts H. Caffeine consumption // Food Chem. Toxicol. - 1996; 34: 119-29.
  11. Juliano L., Griffiths R. A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features // Psychopharmacology. - 2004; 176: 1-29.
  12. Drewnowski A., Rehm C. Sources of caffeine in diets of US children and adults: trends by beverage type and purcgase location // Nutrients. - 2016; 8: 154-66.
  13. Калинин А.Я. Кофеин - друг или враг? // Компетентность. - 2014; 9-10 (120-121): 43-51.
  14. Бессонов В.В., Ханферьян Р.А. Кофеин в питании. Сообщение I. Поступление с питанием и регулирование // Вопр. питания. - 2015; 4: 119
  15. Fredholm B., Bättig K., Holmén J. et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use // Pharmacol. Rev. - 1999; 51 (1): 83-133.
  16. Magkos F., Kavouras S. Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action // Crit. Rev. Food Sci. Nutr. - 2005; 45: 535-62.
  17. S. Teekachunhatean N., Tosri N., Rojanasthien S. et al. Pharmacokinetics of Caffeine following a Single Administration of Coffee Enema versus Oral Coffee Consumption in Healthy Male Subjects // ISRN Pharmacology. - 2013; Article ID 147238. http://dx.doi.org/10.1155/2013/147238
  18. Perera V., Gross A., McLachlan A. Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma // Biomed. Chromatogr. - 2010; 24 (10): 1136-44.
  19. Kamimori G., Karyekar C., Otterstetter R. et al. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers // Inter. J. Pharm. - 2002; 234 (1-2): 159-76.
  20. Fredholm B., Bättig K., Holmén J. et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use // Pharmacol. Rev. - 1999; 51 (1): 83-133.
  21. Arnaud M. The pharmacology of caffeine // Prog. Drug Res. - 1987; 31: 273-313.
  22. Schneider H., Ma L., Glatt H. Extractionless method for the determination of urinary caffeine metabolites using high-performance liquid chromatography coupled with tandem mass spectrometry // J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. - 2003; 789 (2): 227-37.
  23. Kot M., Daniel W. Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat // Pharmacol. Rep. - 2008; 60 (6): 789-97.
  24. Gonzalez A., Hoffman J., Wells A. et al. Effects of Time-Release Caffeine Containing Supplement on Metabolic Rate, Glycerol Concentration and Performance // J. Sports Sci. Med. - 2015; 14 (2): 322-32.
  25. Astrup A., Breum L., Toubro S. et al. The effect and safety of an ephedrine/ caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial // Int. J. Obes. Relat. Metab. Disord. - 1992; 16 (4): 269-77.
  26. Huxtable R. Physiological actions of taurine // Physiolog. Rev. - 1992; 72 (1): 101-63.
  27. Schaffer S. W., Ito T., Azuma J. Clinical significance of taurine // Amino Acids. - 2014; 46 (1): 1-5.
  28. De Luca A., Pierno S., Conte Camerino D. Taurine: the appeal of a safe amino acid for skeletal muscle disorders // J. Transl. Med. - 2015; 13: 243.
  29. Faggiano A., Melis D., Alfieri R. et al. Sulfur amino acids in Cushing’s disease: insight in homocysteine and taurine levels in patients with active and cured disease // J. Clin. Endocrinol. Metab. - 2005; 90: 6616-22.
  30. Sturman J. Taurine in development // J. Nutr. - 1988; 118: 1169-76.
  31. Jansson T. Amino acid transporters in the human placenta // Pediatr. Res. - 2001; 49: 141-7.
  32. Tappaz M. Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations // Neurochemical. Research. - 2004; 29 (1): 83-96.
  33. Ramamoorthy S., Leibach F., Mahesh V. et al. Functional characterization and chromosomal localization of a cloned taurine transporter from human placenta // Biochem. J. - 1994; 300: 893-900.
  34. Norberg S., Powell T., Jansson T. Intrauterine growth restriction is associated with a reduced activity of placental taurine transporters // Pediatr. Res. - 1998; 44: 233-8.
  35. Na-Young Lee, Young-Sook Kang.mailto:yskang@sookmyung.ac.kr Regulation of taurine transport at the blood-placental barrier by calcium ion, PKC activator and oxidative stress conditions // J. Biomed. Sci. - 2010; 17 (Suppl. 1): 37.
  36. Imae M., Asano T., Murakami S. Potential role of taurine in the prevention of diabetes and metabolic syndrome // Amino Acids. - 2014; 46 (1): 81-8.
  37. Ripps H., Shen W. Review: taurine: a “very essential” amino acid // Molecular Vision. - 2012; 18: 2673-86.
  38. Ito T., Schaffer S., Azuma J. The potential usefulness of taurine on diabetes mellitus and its complications // Amino Acids. - 2012; 42 (5): 1529-39.
  39. Hayes K., Carey R., Schmidt S. Retinal degeneration associated with taurine deficiency in the cat // Science. - 1975; 188 (4191): 949-51.
  40. Zeng K., Xu H., Mi M. et al. Effects of taurine on glial cells apoptosis and taurine transporter expression in retina under diabetic conditions // Neurochemical Research. - 2010; 35 (10): 1566-74.
  41. Hansen S. The role of taurine in diabetes and the development of diabetic complications // Diabet. Metab. Res. Rev. - 2001; 17 (5): 330-46.
  42. Di Leo M., Santini S., Cercone S. et al. Chronic taurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats // Amino Acids. - 2002; 23 (4): 401-6.
  43. Di Leo M., Ghirlanda G., Gentiloni Silveri N. et al. Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementations // Free Radical Research. -2003; 37 (3): 323-30.
  44. Han X., Patters A., Jones D. et al. The taurine transporter: mechanisms of regulation // Acta Physiologica. - 2006; 187 (1-2): 61-73.
  45. Franconi F., Miceli M., Fazzini A. et al. Taurine and diabetes. Humans and experimental models. In Advances in Experimental Medicine and Biology / New York, NY, USA: Springer, 1996; 579-82.
  46. Franconi F., Loizzo A., Ghirlanda G. et al. Taurine supplementation and diabetes mellitus // Curr. Opin. Clin. Nutr. Metab. Care. - 2006; 9 (1): 32-6.
  47. Baynes J., Thorpe S. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm // Diabetes. - 1999; 48 (1): 1-9.
  48. Napol Z., Seghieri G., Bianchi L. et. al. Taurine Transporter Gene Expression in Mononuclear Blood Cells of Type 1 Diabetes Patients // J. Diabetes Res. - 2016: 7313162. Published online 2016 Feb 3.
  49. Проскурякова Т.В., Шохонова В.А., Анохин П.К. и др. Безалкогольные кофеинсодержащие тонизирующие напитки: экспериментальное исследование // Наркология. - 2015; 2: 18-30.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ИД "Русский врач", 2016

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах